EPS Creative Health Technology Group Ltd.

Media Center


The enrolment of patients has been initiated in the investigator-initiated clinical trials to which FEF Pharmaceutical Co., Ltd. provides investigational drugs

FEF Pharmaceutical Co., Ltd. and Kyoto University are conducting a collaborative research project aimed at developing a novel treatment for lower extremity artery disease (LEAD).
Kyoto University has released a news release regarding the initiation of the investigator-initiated clinical trial of EIM-001 which is developed by FEF Pharmaceutical Co., Ltd.
Please refer to the press release of Kyoto University Hospital for details.

This site is registered on wpml.org as a development site.